Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course

Ji An Hwang, Sunyoung Kim, Kyung-Wook Jo, Tae Sun Shim

Source: Eur Respir J , 49 (3) 1600537; DOI: 10.1183/13993003.00537-2016
Journal Issue: March
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ji An Hwang, Sunyoung Kim, Kyung-Wook Jo, Tae Sun Shim. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. Eur Respir J , 49 (3) 1600537; DOI: 10.1183/13993003.00537-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005



Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017



A case of familial pulmonary Mycobacterium avium complex disease – experience in Japan
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008


Factors related to response to intermittent treatment of mycobacterium avium complex lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006

Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018



Combined chemotherapy in Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 657s
Year: 2005

Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003



Insufficient serum L-ficolin is associated with the disease progression in pulmonary Mycobacterium avium complex disease
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019

Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017


Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy following the guidelines for treatment
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009


Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease
Source: Eur Respir J, 58 (2) 1902269; 10.1183/13993003.02269-2019
Year: 2021



The second recurrence of Mycobacterium avium complex lung disease after successful treatment for first recurrence
Source: Eur Respir J, 53 (1) 1801038; 10.1183/13993003.01038-2018
Year: 2019



Long-term survival of patients with mycobacterium avium- intracellulare complex pulmonary disease (MAC-PD)
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019


Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

The new “Hesitation Blues”: initiating Mycobacterium avium complex lung disease therapy
Source: Eur Respir J , 49 (3) 1700110; DOI: 10.1183/13993003.00110-2017
Year: 2017


Susceptibility to nontuberculous mycobacterial lung disease
Source: Eur Respir J 2008; 31: 1322-1333
Year: 2008



The effect of combined chemotherapy according to the guidelines on the treatment for Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002